How this works
The math
What the US labels say
- Zepbound, Mounjaro (tirzepatide)
- Says to take it as soon as possible within 4 days (96 hours), and to skip it after that.12
- Ozempic (semaglutide)
- Says to take it as soon as possible within 5 days, and to skip it after that.3
- Wegovy injection (semaglutide)
- Says to take it as soon as possible if the next dose is more than 2 days away, and to skip it if the next dose is less than 2 days away. After 2 or more missed in a row, it says to restart at a lower dose: ask your prescriber.4
- Wegovy pill, Ozempic pill, Rybelsus (oral semaglutide)
- Says to skip it and take the next dose the following day.45
- Foundayo (orforglipron)
- Says to take it as soon as possible and not to double the next dose. After 7 or more missed in a row, it says to restart at a lower dose: ask your prescriber.6
The tool preserves the next regular local dose time through clock changes and compares exact elapsed hours. Most labels include the exact limit; only the US injectable semaglutide for weight management wording leaves the 48-hour equality unstated, so the tool asks there.
What the label shows
US
Wegovy (semaglutide)
The US label says to take a missed dose if the next dose is more than 2 days away; if less, skip it. After 2 or more missed doses in a row, ask your prescriber about restarting.4
Ozempic (semaglutide)
The US label says to take a missed dose as soon as possible within 5 days, otherwise skip it and resume on the regular day.3
Zepbound (tirzepatide)
The US label says to take a missed dose as soon as possible within 4 days (96 hours), otherwise skip it and resume on the regular day. Keep at least 3 days (72 hours) between doses.12
Mounjaro (tirzepatide)
The US label says to take a missed dose as soon as possible within 4 days (96 hours), otherwise skip it and resume on the regular day. Keep at least 3 days (72 hours) between doses.12
Wegovy pill (oral semaglutide)
The US semaglutide tablet label says to skip the missed dose and take the next dose the following day.45
Ozempic pill (oral semaglutide)
The US semaglutide tablet label says to skip the missed dose and take the next dose the following day.45
Rybelsus (oral semaglutide)
The US semaglutide tablet label says to skip the missed dose and take the next dose the following day.45
Foundayo (orforglipron)
The US label says to take it as soon as possible and not double the next dose. After 7 or more missed doses, ask your prescriber how to restart.6
EU
Wegovy (semaglutide)
The EU label says as soon as possible within 5 days; after that, skip it. If several doses are missed, ask your prescriber about restarting.7
Ozempic (semaglutide)
The EU label says as soon as possible within 5 days; after that, skip it.8
Mounjaro (tirzepatide)
The EU label says as soon as possible within 4 days; after that, skip it. Keep at least 3 days between doses.9
Japan
Wegovy (semaglutide)
The Japanese label says to take a missed dose if the next scheduled dose is at least 48 hours away; otherwise skip it.1112
Ozempic (semaglutide)
The Japanese label says to take a missed dose if the next scheduled dose is at least 48 hours away; otherwise skip it.1112
Zepbound (tirzepatide)
The Japanese label says to take a missed dose if the next scheduled dose is at least 72 hours away; otherwise skip it.1314
Mounjaro (tirzepatide)
The Japanese label says to take a missed dose if the next scheduled dose is at least 72 hours away; otherwise skip it.1314
Rybelsus (oral semaglutide)
The semaglutide tablet instructions say to skip the missed tablet and take the next dose the following day. Do not double up.15
Before you act on this
Your prescriber’s instructions come first. If they told you something different, follow them.
Labels warn against doubling up. Zepbound’s says not to take 2 doses within 3 days, and Foundayo’s says not to double the next dose.16 If you’ve missed several doses, ask your prescriber how to restart before your next one.
Always follow your doctor’s or prescriber’s advice and guidance. Talk to your prescriber before changing your dose.
For information only, not medical advice. Verify results with your healthcare provider; Onederland accepts no liability for use of these tools.
- Runs on this device. Nothing you type is sent anywhere.
- Every figure names its source, below.
- Education, not medical advice. Your prescriber comes first.
Sources
Sources
- Zepbound (tirzepatide) injection, US prescribing information, revised 08/2026. accessdata.fda.gov
- Mounjaro (tirzepatide) injection, US prescribing information, revised 08/2026. accessdata.fda.gov
- Ozempic (semaglutide) injection, US prescribing information, revised 05/2026. accessdata.fda.gov
- Wegovy (semaglutide) injection and tablets, US prescribing information, revised 06/2026. accessdata.fda.gov
- Rybelsus and Ozempic (semaglutide) tablets, US prescribing information, revised 01/2026. accessdata.fda.gov
- Foundayo (orforglipron) tablets, US prescribing information, revised 07/2026. dailymed.nlm.nih.gov
- EU product information for semaglutide for weight management (tablets: summary of product characteristics, section 4.2), updated 21 September 2026. ema.europa.eu
- EU product information: injectable semaglutide for type 2 diabetes. ema.europa.eu
- EU product information: tirzepatide. ema.europa.eu
- EU product information: oral semaglutide for type 2 diabetes. ema.europa.eu
- Japanese prescribing information: injectable semaglutide for obesity, June 2026. pmda.go.jp
- Japanese patient medicine guide: injectable semaglutide for type 2 diabetes, March 2024. info.pmda.go.jp
- Japanese prescribing information: tirzepatide for obesity, September 2026. pmda.go.jp
- Japanese prescribing information: tirzepatide for type 2 diabetes. medical.lilly.com
- Japanese patient medicine guide: oral semaglutide for type 2 diabetes, March 2024. info.pmda.go.jp
Label sources last checked on October 30, 2026. Onederland summarizes them; your prescriber and the full prescribing information come first.
